(fra kommisjonsforordningen)

(1) Co-formulants are described in point (c) of Article 2(3) of Regulation (EC) No 1107/2009 as substances or preparations which are used or intended to be used in a plant protection product or adjuvant but are neither active substances nor safeners or synergists. 

(2) In accordance with Article 27(1) of Regulation (EC) No 1107/2009, co-formulants are unacceptable in plant protection products if their residues, consequent on application consistent with good plant protection practice, and having regard to realistic conditions of use, have a harmful effect on human or animal health or on groundwater or an unacceptable effect on the environment, or if their use, consequent on application consistent with good plant protection practice, and having regard to realistic conditions of use, has a harmful effect on human or animal health or has an unacceptable effect on plants, plant products or the environment. Such unacceptable co-formulants are listed in Annex III to Regulation (EC) No 1107/2009. 

(3) In accordance with Article 27(3) of Regulation (EC) No 1107/2009, the Commission may review co-formulants at any time and may take into account relevant information provided by Member States. In particular, it may take into account notifications provided by the Member States in accordance with the rules for the identification of unacceptable co-formulants set out in Commission Implementing Regulation (EU) 2023/574. 

(4) In accordance with Articles 3 and 4 of Implementing Regulation (EU) 2023/574, Member States have identified 12 new substances that are found to be unacceptable for use as co-formulants in plant protection products authorised under Regulation (EC) No 1107/2009, because they fulfil at least one of the criteria set out in the Annex to Implementing Regulation (EU) 2023/574. 

(5) Among those co-formulants, there are substances that have a harmonised classification as carcinogens, category 1A or 1B, as mutagens, category 1A or 1B, or as toxic to reproduction, category 1A or 1B, in accordance with Annex VI to Regulation (EC) No 1272/2008 of the European Parliament and of the Council, substances identified as persistent, bioaccumulative and toxic (PBT) or very persistent and very bioaccumulative (vPvB), in accordance with Article 57, points (d) and (e), of Regulation (EC) No 1907/2006 of the European Parliament and of the Council, substances listed as persistent organic pollutants (POPs) under Regulation (EU) 2019/1021 of the European Parliament and of the Council and substances not approved for use in biocidal products for product-type 6 (in-can preservatives) under Regulation (EU) No 528/2012 of the European Parliament and of the Council. 

(6) In accordance with Article 5 of Implementing Regulation (EU) 2023/574, the Commission listed those unacceptable co-formulants on its website. 

(7) It is therefore appropriate to amend Annex III to Regulation (EC) No 1107/2009 to include the additional substances that Member States have identified as unacceptable for their use as co-formulants in plant protection products or adjuvants. 

(8) Co-formulants to be listed in Annex III to Regulation (EC) No 1107/2009 may also be contained in adjuvants placed on the market. As detailed rules for the authorisation of adjuvants have not yet been established, Member States may continue to apply national provisions as regards adjuvants in accordance with Article 81(3) of that Regulation. As that Regulation aims to prevent the placing on the market or use of adjuvants containing prohibited co-formulants, it is necessary to ensure that also adjuvants, to be mixed with plant protection products, do not contain any of those unacceptable co-formulants. 

(9) Member States should be provided with time to review the composition of the plant protection products and adjuvants currently authorised in their territory, to assess whether they contain any co-formulants listed in Annex III to Regulation (EC) No 1107/2009 by this Regulation and to withdraw or amend authorisations for plant protection products and adjuvants containing those co-formulants. 

(10) To allow for the orderly phasing out of products and minimise potential disruption to users and supply chains, in the case of plant protection products or adjuvants containing a co-formulant listed in Annex III to Regulation (EC) No 1107/2009 by this Regulation, Member States may grant a grace period, where appropriate and in accordance with Article 46, first subparagraph, of that Regulation or, where applicable, under national provisions governing the authorisation of adjuvants. 

(11) Co-formulants listed in Annex III to Regulation (EC) No 1107/2009 by this Regulation may be present as unintentional impurities in other co-formulants, which as such are acceptable for use in plant protection products or adjuvants. Therefore, the individual concentration of the unacceptable co-formulants in the finished plant protection product or adjuvant should be less than 0,1 % weight by weight (w/w) or less than a specific concentration limit related to CMR properties (carcinogenic, mutagenic and reprotoxic), when established in Annex VI to Regulation (EC) No 1272/2008 for the unacceptable co-formulant at a level lower than 0,1 % weight by weight (w/w), in order to be considered as acceptable unintentional impurity, unless a different limit is provided due to technical limitations of relevant analytical methods. 

(12) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,